TOPIA MEDTECH

Office B 215 to 223 Siddharth Annexe-3, Vemli Dumad Vadodara Gujarat India 391740 All India companies → — Founded 2025

Imaging AI Specialist Specialty-Focused AI Wearables / RPM

Neurology Radiology

Neurology AI Radiology & Imaging AI

Claim this company

Products

Alzevita

TOPIA MEDTECH LIMITED

Neurology AI

Alzevita is a cloud-based AI-powered medical image processing software that automates hippocampal segmentation and volumetric analysis from brain MRI scans, assisting neurologists and radiologists in diagnosing and monitoring neurodegenerative conditions.

Contact vendor for pricing

See all 1 product →

About TOPIA MEDTECH

TOPIA MEDTECH is a healthcare AI company dedicated to advancing medical technology through smart, accessible solutions. The company specializes in wearable diagnostics and AI-powered imaging, aiming to enhance clinical efficiency and support data-driven decision-making for healthcare professionals.

Their flagship products include FibriArt, a continuous ECG monitoring patch designed for cardiac care. FibriArt enables cardiologists and other medical physicians to detect arrhythmias, such as Atrial Fibrillation (AFib) and Atrial Flutter (AFL), and monitor overall heart health with real-time, accurate insights. Additionally, TOPIA MEDTECH offers Alzevita, an AI-based MRI segmentation and volumetry tool. Alzevita assists radiologists with rapid and consistent brain imaging analysis, particularly for automated hippocampal segmentation and volumetric reporting, which is crucial for understanding neurodegenerative disorders like Alzheimer’s. The company’s broader mission, often in conjunction with Topia Life Sciences, extends to leveraging AI for drug discovery and developing next-generation therapies.

Focus Areas

wearable diagnostics AI-driven medical imaging cardiac health monitoring neuroimaging arrhythmia detection Alzheimer's monitoring brain MRI analysis hippocampal segmentation volumetric analysis

Business Intelligence

Technology	AI-powered cloud platform for ECG analysis and arrhythmia detection; AI-powered cloud-based medical image processing software for hippocampal segmentation and volumetry. Supports DICOM and NIfTI formats. Alzevita's algorithm is locked and requires FDA review for modifications.
FDA Clearances	1 cleared products (estimated)

What Physicians Need to Know

Wearable Diagnostics & Cardiac Health

TOPIA MEDTECH's FibriArt is a smart, continuous ECG monitoring patch that captures medical-grade ECG data on a smartphone. It provides accurate, real-time insights into heart health, enabling the early detection and diagnosis of arrhythmias such as Atrial Fibrillation (AFib) and Atrial Flutter (AFL).

AI-Driven Neuroimaging & Alzheimer's Monitoring

Alzevita, their AI-based MRI segmentation and volumetry tool, streamlines brain MRI analysis. It offers automated hippocampal segmentation and volumetric reporting, crucial for monitoring conditions like Alzheimer's disease by providing consistent and reproducible imaging insights.

Key Differentiators

TOPIA MEDTECH stands out by offering smart, accessible medical technology that enhances clinical efficiency. They empower healthcare professionals with data-driven tools for faster, more accurate clinical decisions and improved patient outcomes. Their patient-first approach and specialized expertise in cardiac and neuroimaging technologies are central to their mission.

Technology Stack

Their solutions leverage AI-powered algorithms for advanced medical imaging analysis and data interpretation. FibriArt integrates medical-grade ECG technology with smartphone connectivity, while Alzevita utilizes automated image analysis and deep learning models for precise brain MRI segmentation and volumetric reporting.

Physician Tip

For cardiologists and general practitioners, FibriArt offers a convenient and reliable tool for continuous, real-time arrhythmia detection and remote patient monitoring, aiding in early intervention and improved cardiac care. For radiologists and neurologists, Alzevita significantly enhances workflow efficiency by automating complex brain MRI analysis, particularly hippocampal segmentation and volumetric reporting. This provides consistent, reproducible insights critical for diagnosing and monitoring neurodegenerative diseases like Alzheimer's, addressing the growing demand for faster and more accurate diagnostics. Both products aim to provide data-driven insights that support better and faster clinical decision-making.

While specific integration partners are not detailed, the nature of TOPIA MEDTECH's products (smartphone-connected wearables and AI imaging tools for labs) suggests a strong need for seamless integration with existing healthcare IT infrastructure. This would likely include Electronic Health Record (EHR) or Electronic Medical Record (EMR) systems for patient data management, and Picture Archiving and Communication Systems (PACS) for medical imaging workflows, to ensure comprehensive data flow and accessibility for physicians.

At a glance

Founded 2025

HQ Office B 215 to 223 Siddharth Annexe-3, Vemli Dumad Vadodara Gujarat India 391740 · India

Team size 1-10

FDA clearances 1 (estimated)

Products 1

Products by TOPIA MEDTECH

1 product in the directory

Alzevita

TOPIA MEDTECH LIMITED

Neurology AI

Contact vendor for pricing

What the Web Says

TOPIA MEDTECH specializes in smart, accessible medical technology, focusing on wearable diagnostics and AI-powered imaging solutions for cardiac health and cognitive monitoring. Their flagship products include FibriArt, a smart ECG patch for continuous heart monitoring, and Alzevita, an AI-based MRI segmentation and volumetry tool for brain imaging analysis. While there's limited direct product review data for TOPIA MEDTECH specifically, general sentiment around the company as an employer is mixed, with some positive experiences reported by interns and some negative feedback regarding management and startup culture.

Overall: Mixed

Strengths

Opportunity for significant growth and hands-on experience for interns
Supportive environment and personal appreciation (reported by some interns)
Time and location flexibility (reported by some interns)
FibriArt provides accurate, real-time insights into heart health and arrhythmia diagnosis
Alzevita streamlines brain MRI analysis with automated hippocampal segmentation and volumetric reporting
Products aim to improve lives through innovative, easy-to-use medical technologies

Limitations

Horrible workplace experience reported by some employees
Under-appreciation for work and unprofessional CEO attitude (reported by one intern)
Terrible company and poor management (reported by some employees)
Chaotic startup environment
Unfriendly, unprofessional, and low morale environment (reported by some employees)
Lack of energizing work tasks and general feeling of work happiness (reported by some employees)

Based on reviews from: Indeed.com, Prospeo, Topia MedTech Website, accessdata.fda.gov, G2

Last updated: 2026-07-19

Videos

News, demos, and interviews about TOPIA MEDTECH.

Loading videos...

Videos load interactively. If none appear, search YouTube for TOPIA MEDTECH →

View all on YouTube

Press & Coverage

Topia MedTech

A Proud Milestone: Alzevita Receives FDA 510(k) Clearance

Topia MedTech's Alzevita, an Automated Radiological Image Processing Software, received FDA 510(k) clearance on January 6, 2026, confirming its rigorous standards for safety and performance. This AI-powered platform helps clinicians and researchers understand brain MRI data by providing quantitative, longitudinal insights into brain changes over time.

2026-01

FDA

K252670 - 510(k) Premarket Notification - FDA

This FDA document details the 510(k) Premarket Notification for Alzevita by TOPIA MEDTECH LIMITED, which was received on August 25, 2025, and received a 'Substantially Equivalent' decision on December 19, 2025. Alzevita is classified as an Automated Radiological Image Processing Software (21 CFR 892.2050) and is intended for use by neurologists and radiologists for automated labeling, visualization, and volumetric measurement of the hippocampus from high-resolution T1-weighted MRI images.

2025-12

unknown

AI in Medical Devices Market Size & Share, Growth Analysis 2035

A report published on April 9, 2026, mentions TOPIA MEDTECH LIMITED and its Alzevita product in the context of AI in medical devices, noting its FDA clearance date of December 19, 2025. The AI in Medical Devices Market is projected to reach USD 123.4 billion by 2035, growing at a CAGR of 28.2% from 2026.

2026-04

UniFuncs

u65afu5766u798f2026AIu6307u6570u62a5u544auff1au5168u7403AIu683cu5c40u5de8u53d8 - UniFuncs

The Stanford 2026 AI Index Report, published on April 14, 2026, lists Alzevita by TOPIA MEDTECH LIMITED as an FDA-approved AI medical device on December 19, 2025. The report highlights significant advancements in AI capabilities, with the industry contributing over 90% of frontier models and achieving breakthroughs in scientific problems and multimodal reasoning.

2026-04

Topia MedTech

Topia MedTech - The Future of Healthcare Innovation

Topia MedTech is advancing healthcare with smart, accessible medical technology, specializing in wearable diagnostics and AI-powered imaging solutions. Their flagship products are FibriArt, a continuous ECG monitoring patch for cardiac care, and Alzevita, an AI-based MRI segmentation and volumetry tool for brain imaging analysis.

unknown

Prospeo

Topia MedTech Overview, Address & Contact - Prospeo

Topia MedTech, based in the United Kingdom, focuses on wearable diagnostics and medical imaging solutions, with products like FibriArt for continuous heart monitoring and Alzevita for cognitive monitoring. The company has an estimated annual revenue of $769,995 and has not yet raised any funding.

unknown

Mathews Open Access Journals

joint-event-on-icamp-neuro-care-2026-conference-abstract-book.pdf - Mathews Open Access Journals

Topia Medtech Ltd. is mentioned in the abstract book for the ICAMP-Neuro Care 2026 conference, scheduled for March 23-25, 2026, in Singapore. The company is spearheading the launch of a neurodiagnostic software platform for early and precise identification of neurological disorders, bridging scientific research and clinical application.

2026-03

Tracxn

TOPIA MEDTECH PRIVATE LIMITED - 2026 Company Profile - Tracxn

TOPIA MEDTECH PRIVATE LIMITED was incorporated on April 10, 2025, in India, and is registered at the Registrar of Companies, ROC Ahmedabad. The company is a developer of AI-powered medical devices for cardiac and brain health, with an authorized and paid-up share capital of u20b91L.

2026-07

Frequently Asked Questions

What core medical technologies does TOPIA MEDTECH offer for physicians and healthcare administrators?

TOPIA MEDTECH specializes in wearable diagnostics and AI-powered imaging solutions. Their flagship products include FibriArt, a continuous ECG monitoring patch for cardiac care and arrhythmia detection, and Alzevita, an AI-based tool for brain MRI segmentation and volumetry, particularly for hippocampal analysis in conditions like Alzheimer's.

How do TOPIA MEDTECH's products, FibriArt and Alzevita, specifically aid in cardiac health monitoring and neuroimaging?

FibriArt is a smart ECG patch that captures medical-grade ECG on a smartphone, providing accurate insights into heart health and enabling the diagnosis of arrhythmias such as Afib and AFL. Alzevita streamlines brain MRI analysis through automated hippocampal segmentation and volumetric reporting, offering consistent and reproducible imaging insights for radiologists and imaging labs.

What is TOPIA MEDTECH's approach to regulatory compliance for its medical devices and AI solutions?

TOPIA MEDTECH aims to advance healthcare through smart, accessible medical technology, which inherently requires adherence to medical device regulations. While specific certifications like FDA or CE Mark are not detailed in the provided information, the broader MedTech industry emphasizes robust risk management, cybersecurity, and quality management systems aligned with standards like ISO 13485 for regulatory compliance.

Can you provide information on the pricing model for TOPIA MEDTECH's products, FibriArt and Alzevita?

Specific pricing details for FibriArt and Alzevita are not publicly available in the provided search results. Typically, pricing for specialized medical technology like wearable diagnostics and AI-driven imaging solutions is determined through direct consultation with the company, often involving factors such as volume, integration needs, and specific feature sets required by healthcare providers.

What kind of customer support and technical assistance does TOPIA MEDTECH offer to healthcare professionals?

TOPIA MEDTECH's website includes a 'Contact Us' section for inquiries. While detailed support channels for healthcare professionals are not explicitly outlined, medical technology companies generally provide dedicated technical support, training, and customer service to ensure effective integration and use of their products in clinical settings.

Does TOPIA MEDTECH engage in partnerships with healthcare institutions or other technology providers?

TOPIA MEDTECH has an Associate Director for Strategic Alliances and Business Development, indicating an active pursuit of strategic partnerships and commercial development. This suggests a focus on collaborations to support the growth and market adoption of their innovative medical technologies.

What is the current company stability and funding status of TOPIA MEDTECH?

TOPIA MEDTECH is a relatively small company, reported to have approximately 1-10 employees with an estimated annual revenue of around $769,995. The company has not publicly reported any funding rounds specific to 'TOPIA MEDTECH' in the provided information.

Related Companies

Suggest an Edit →